166 related articles for article (PubMed ID: 33298901)
21. The expression and crucial roles of BMP signaling in development of smooth muscle progenitor cells in the mouse embryonic gut.
Torihashi S; Hattori T; Hasegawa H; Kurahashi M; Ogaeri T; Fujimoto T
Differentiation; 2009 Mar; 77(3):277-89. PubMed ID: 19272526
[TBL] [Abstract][Full Text] [Related]
22. Low-level laser irradiation enhances BMP-induced osteoblast differentiation by stimulating the BMP/Smad signaling pathway.
Hirata S; Kitamura C; Fukushima H; Nakamichi I; Abiko Y; Terashita M; Jimi E
J Cell Biochem; 2010 Dec; 111(6):1445-52. PubMed ID: 20830741
[TBL] [Abstract][Full Text] [Related]
23. Quantitative kinetics analysis of BMP2 uptake into cells and its modulation by BMP antagonists.
Alborzinia H; Schmidt-Glenewinkel H; Ilkavets I; Breitkopf-Heinlein K; Cheng X; Hortschansky P; Dooley S; Wölfl S
J Cell Sci; 2013 Jan; 126(Pt 1):117-27. PubMed ID: 23077176
[TBL] [Abstract][Full Text] [Related]
24. Promotive effects of bone morphogenetic protein 2 on angiogenesis in hepatocarcinoma via multiple signal pathways.
Zuo WH; Zeng P; Chen X; Lu YJ; Li A; Wu JB
Sci Rep; 2016 Nov; 6():37499. PubMed ID: 27886213
[TBL] [Abstract][Full Text] [Related]
25. LncRNA AWPPH promotes the proliferation, migration and invasion of ovarian carcinoma cells via activation of the Wnt/β‑catenin signaling pathway.
Yu G; Wang W; Deng J; Dong S
Mol Med Rep; 2019 May; 19(5):3615-3621. PubMed ID: 30896797
[TBL] [Abstract][Full Text] [Related]
26. Bone Morphogenetic Protein 2 Promotes Human Trophoblast Cell Invasion by Inducing Activin A Production.
Zhao HJ; Chang HM; Zhu H; Klausen C; Li Y; Leung PCK
Endocrinology; 2018 Jul; 159(7):2815-2825. PubMed ID: 29846546
[TBL] [Abstract][Full Text] [Related]
27. Dual-specificity phosphatase 5 suppresses ovarian cancer progression by inhibiting IL-33 signaling.
Wang L; Hu J; Qiu D; Gao H; Zhao W; Huang Y; Jiang T; Zhou J; Chen Y
Am J Transl Res; 2019; 11(2):844-854. PubMed ID: 30899384
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-216a promotes the metastasis and epithelial-mesenchymal transition of ovarian cancer by suppressing the PTEN/AKT pathway.
Liu H; Pan Y; Han X; Liu J; Li R
Onco Targets Ther; 2017; 10():2701-2709. PubMed ID: 28579808
[TBL] [Abstract][Full Text] [Related]
29. GDF5 and BMP2 inhibit apoptosis via activation of BMPR2 and subsequent stabilization of XIAP.
Liu Z; Shen J; Pu K; Katus HA; Plöger F; Tiefenbacher CP; Chen X; Braun T
Biochim Biophys Acta; 2009 Dec; 1793(12):1819-27. PubMed ID: 19782107
[TBL] [Abstract][Full Text] [Related]
30. Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer.
Kanlikilicer P; Bayraktar R; Denizli M; Rashed MH; Ivan C; Aslan B; Mitra R; Karagoz K; Bayraktar E; Zhang X; Rodriguez-Aguayo C; El-Arabey AA; Kahraman N; Baydogan S; Ozkayar O; Gatza ML; Ozpolat B; Calin GA; Sood AK; Lopez-Berestein G
EBioMedicine; 2018 Dec; 38():100-112. PubMed ID: 30487062
[TBL] [Abstract][Full Text] [Related]
31. SMAD specific E3 ubiquitin protein ligase 1 promotes ovarian cancer cell migration and invasion via the activation of the RhoA/ROCK signaling pathway.
Wang W; Du H; Liu H; Hu F; Liu G
Oncol Rep; 2019 Jan; 41(1):668-676. PubMed ID: 30542716
[TBL] [Abstract][Full Text] [Related]
32. L51P - A BMP2 variant with osteoinductive activity via inhibition of Noggin.
Albers CE; Hofstetter W; Sebald HJ; Sebald W; Siebenrock KA; Klenke FM
Bone; 2012 Sep; 51(3):401-6. PubMed ID: 22750402
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of RNA-Binding Protein Musashi-1 Suppresses Malignant Properties and Reverses Paclitaxel Resistance in Ovarian Carcinoma.
Chen H; Liu J; Wang H; Cheng Q; Zhou C; Chen X; Ye F
J Cancer; 2019; 10(6):1580-1592. PubMed ID: 31031868
[No Abstract] [Full Text] [Related]
34. Conditioned medium from bone marrow-derived mesenchymal stem cells inhibits vascular calcification through blockade of the BMP2-Smad1/5/8 signaling pathway.
Wang S; Hu S; Wang J; Liu Y; Zhao R; Tong M; Cui H; Wu N; Chen X
Stem Cell Res Ther; 2018 Jun; 9(1):160. PubMed ID: 29895327
[TBL] [Abstract][Full Text] [Related]
35. HOXD-AS1 promotes cell proliferation, migration and invasion through miR-608/FZD4 axis in ovarian cancer.
Wang Y; Zhang W; Wang Y; Wang S
Am J Cancer Res; 2018; 8(1):170-182. PubMed ID: 29416930
[TBL] [Abstract][Full Text] [Related]
36. Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growth.
Hover LD; Young CD; Bhola NE; Wilson AJ; Khabele D; Hong CC; Moses HL; Owens P
Cancer Lett; 2015 Nov; 368(1):79-87. PubMed ID: 26235139
[TBL] [Abstract][Full Text] [Related]
37. Gremlin-1: An endogenous BMP antagonist induces epithelial-mesenchymal transition and interferes with redifferentiation in fetal RPE cells with repeated wounds.
Li D; Yuan D; Shen H; Mao X; Yuan S; Liu Q
Mol Vis; 2019; 25():625-635. PubMed ID: 31700227
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene.
Cheng SL; Lou J; Wright NM; Lai CF; Avioli LV; Riew KD
Calcif Tissue Int; 2001 Feb; 68(2):87-94. PubMed ID: 11310352
[TBL] [Abstract][Full Text] [Related]
39. Dynamic activation of bone morphogenetic protein signaling in collagen-induced arthritis supports their role in joint homeostasis and disease.
Daans M; Lories RJ; Luyten FP
Arthritis Res Ther; 2008; 10(5):R115. PubMed ID: 18816401
[TBL] [Abstract][Full Text] [Related]
40. CCL18 from ascites promotes ovarian cancer cell migration through proline-rich tyrosine kinase 2 signaling.
Lane D; Matte I; Laplante C; Garde-Granger P; Carignan A; Bessette P; Rancourt C; Piché A
Mol Cancer; 2016 Sep; 15(1):58. PubMed ID: 27613122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
